scholarly article | Q13442814 |
P819 | ADS bibcode | 1993PNAS...90..999L |
P356 | DOI | 10.1073/PNAS.90.3.999 |
P932 | PMC publication ID | 45798 |
P698 | PubMed publication ID | 8430113 |
P5875 | ResearchGate publication ID | 14769423 |
P2093 | author name string | J P Thiery | |
V E Koteliansky | |||
M A Glukhova | |||
M G Frid | |||
X Sastre | |||
D Lazard | |||
P2860 | cites work | The myoD Gene Family: Nodal Point During Specification of the Muscle Cell Lineage | Q24310740 |
Human smooth muscle VLA-1 integrin: purification, substrate specificity, localization in aorta, and expression during development | Q24678731 | ||
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells | Q28262541 | ||
Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas | Q28274428 | ||
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. | Q33685386 | ||
Plasticity of the differentiated state | Q34379462 | ||
Differentiation requires continuous regulation | Q35016700 | ||
Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. | Q35818900 | ||
Intermediate-sized filaments of the prekeratin type in myoepithelial cells | Q36201230 | ||
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes | Q36211832 | ||
A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation | Q36216808 | ||
Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. | Q37821791 | ||
The mysteries of the myofibroblast (partially) unmasked | Q37942707 | ||
Epithelial cell adhesion mechanisms | Q38766080 | ||
Patterns of expression of keratin 17 in human epithelia: dependency on cell position. | Q42490939 | ||
Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody | Q42518578 | ||
High frequency of cytokeratin-producing smooth muscle cells in human atherosclerotic plaques | Q44211422 | ||
Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. | Q44245074 | ||
Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines | Q58065088 | ||
Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues | Q60305997 | ||
Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin | Q67555148 | ||
Expression of cytokeratin 8 in human aortic smooth muscle cells | Q67702132 | ||
Characterization of myosin heavy chains in cultured aorta smooth muscle cells. A comparative study | Q68994037 | ||
Immunohistochemical localization of smooth muscle myosin in normal human tissues | Q69883854 | ||
Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes | Q70128809 | ||
Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells | Q70344761 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 999-1003 | |
P577 | publication date | 1993-02-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue | |
P478 | volume | 90 |
Q58423595 | A Practical Approach to the Use of Immunohistochemistry in the Diagnosis and Management of Breast Disease |
Q53322172 | A novel role of thrombospondin-1 in cervical carcinogenesis: inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer. |
Q33738053 | A smooth muscle-like origin for beige adipocytes |
Q41073905 | Adhesion of Hematopoietic Precursors to Human Stroma: Studies Using Normal Marrow Stromal Myofibroblasts and a Stromal Cell Line Transformed by SV40. |
Q35794930 | Adhesion systems in normal breast and in invasive breast carcinoma |
Q42135353 | Alpha smooth muscle actin positive stromal cells in gastric carcinoma |
Q47893420 | Bottom-up assembly of salivary gland microtissues for assessing myoepithelial cell function. |
Q64911156 | CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms. |
Q36433437 | Can widely used cell type markers predict the suitability of immortalized or primary mammary epithelial cell models? |
Q35763343 | Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer |
Q42459603 | Cell-specific transcription of the smooth muscle gamma-actin gene requires both positive- and negative-acting cis elements. |
Q36643285 | Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer |
Q47604342 | Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms |
Q39367207 | Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts |
Q73670358 | Clinicopathological significance of tumor nest configuration in patients with esophageal squamous cell carcinoma |
Q40732854 | Conditioned medium from MCF-7 cell line induces myofibroblast differentiation, decreased cell proliferation, and increased apoptosis in cultured normal fibroblasts but not in fibroblasts from malignant breast tissue. |
Q41500728 | Contribution of adventitial myofibroblasts to vascular remodeling and lesion formation after experimental angioplasty in pig coronary arteries |
Q33500786 | Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based? |
Q38982080 | Defining the Cardiac Fibroblast |
Q30472755 | Demonstration of aromatase activity and its regulation in breast tumor and benign breast fibroblasts |
Q33594775 | Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma |
Q81419887 | Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells |
Q57011284 | Differential Expression of Myoepithelial Markers in Salivary, Sweat and Mammary Glands |
Q35570992 | Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma |
Q37241761 | Differential expression of high molecular weight caldesmon in colorectal pericryptal fibroblasts and tumour stroma |
Q51366926 | Distribution of aldehyde dehydrogenase 1-positive stem cells in benign mammary tissue from women with and without breast cancer. |
Q38451855 | Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples |
Q40679478 | Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse |
Q34792452 | Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells |
Q41146404 | Expression of calponin in periglomerular myofibroblasts of rat kidney with experimental chronic injuries |
Q24670176 | Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues |
Q71686128 | Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia |
Q38612486 | Expression of smooth muscle calponin in synovial sarcoma |
Q33547056 | Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation |
Q91585014 | Fibroblast as a critical stromal cell type determining prognosis in prostate cancer |
Q90138987 | Fibrosis and cancer: A strained relationship |
Q35586468 | Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone |
Q29619348 | Friends or foes - bipolar effects of the tumour stroma in cancer |
Q52321654 | From passive diffusion to active cellular migration in mathematical models of tumour invasion. |
Q45063910 | Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs |
Q35749008 | Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching |
Q35746429 | Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery |
Q73268984 | Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle |
Q58201003 | Heterogeneity of smooth muscle-associated proteins in mammalian brain microvasculature |
Q42859779 | High molecular weight caldesmon positive stromal cells in the capsule of hepatocellular carcinomas |
Q43011324 | High molecular weight caldesmon positive stromal cells in the capsule of thyroid follicular tumours and tumour-like lesions |
Q47821269 | Human fibroblasts from normal and malignant breast tissue grown in vitro show a distinct senescence profile and telomerase activity. |
Q41247020 | Human foetal lung (IMR-90) cells: myofibroblasts with smooth muscle-like contractile properties |
Q44205803 | Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells |
Q30442152 | Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells |
Q35543455 | Immunocytochemistry of myoepithelial cells in the salivary glands |
Q47420313 | Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins |
Q46201393 | Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers |
Q42281477 | Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis. |
Q35749344 | Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors |
Q35118918 | Interleukin-1β attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-β1 |
Q38423864 | Intracellular signaling of cardiac fibroblasts |
Q47963644 | Is p63 reliable in detecting microinvasion in ductal carcinomain situ of the breast? |
Q33302192 | Loss of myoepithelium is variable in solid papillary carcinoma of the breast |
Q40940062 | Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes |
Q34282358 | Mammary stem cells have myoepithelial cell properties |
Q49443192 | Molecular interphase between extracellular matrix & cancer cells |
Q42515255 | Myoepithelial cell differentiation in the developing mammary gland: progressive acquisition of smooth muscle phenotype |
Q24813615 | Myoepithelial cells: good fences make good neighbors |
Q33557658 | Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia |
Q42459925 | Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma |
Q40168174 | Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells |
Q41368727 | Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. |
Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
Q40928947 | N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. |
Q64074287 | NAB 2-Expressing Cancer-Associated Fibroblast Promotes HNSCC Progression |
Q57158003 | Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering |
Q36550763 | Negative regulation of the vascular smooth muscle alpha-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins |
Q81277505 | Non-vascular smooth muscle cells in the human choroid: distribution, development and further characterization |
Q24554301 | P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype |
Q37254063 | PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis |
Q41727237 | Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors |
Q35923507 | Pathological situations characterized by altered actin isoform expression |
Q37364696 | Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis |
Q71496340 | Placental villous stroma as a model system for myofibroblast differentiation |
Q33678437 | Plasticity of mammary epithelia during normal development and neoplastic progression |
Q41446062 | Potential role of the adventitia in arteritis and atherosclerosis |
Q33682607 | Prediction of cell type-specific gene modules: identification and initial characterization of a core set of smooth muscle-specific genes |
Q55003632 | Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. |
Q39008511 | Revelation of fibroblast protein commonalities and differences and their possible roles in wound healing and tumourigenesis using co-culture models of cells. |
Q34584808 | Role of myofibroblasts at the invasion front |
Q35735316 | Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression |
Q35170428 | Role of tissue stroma in cancer cell invasion |
Q38882752 | Shed proteoglycans in tumor stroma. |
Q91701093 | Smooth muscle: a stiff sculptor of epithelial shapes |
Q88619393 | Spatially correlated phenotyping reveals K5-positive luminal progenitor cells and p63-K5/14-positive stem cell-like cells in human breast epithelium |
Q38945166 | Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells |
Q37295456 | Stromal cells in the human gut show ultrastructural features of fibroblasts and smooth muscle cells but not myofibroblasts |
Q36013308 | Structural components of the nonstriated contractile apparatuses in the Caenorhabditis elegans gonadal myoepithelial sheath and their essential roles for ovulation |
Q37862154 | Tangled fibroblasts in tumor-stroma interactions |
Q35569799 | Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. |
Q26783022 | The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis |
Q33579592 | The actin-binding protein caldesmon is in spleen and lymph nodes predominately expressed by smooth-muscle cells, reticular cells, and follicular dendritic cells |
Q39765351 | The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization |
Q24800054 | The importance of being a myoepithelial cell |
Q37053170 | The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine |
Q40342271 | The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells |
Q41121042 | The role of fibroblasts in tumor behavior |
Q50275568 | Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation |
Q41283928 | Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif |
Q77228620 | Transforming growth factor beta1 involvement in the conversion of fibroblasts to smooth muscle cells in the rabbit bladder serosa |
Q36549555 | Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease |
Q35141434 | Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression |
Q93336606 | Turning foes to friends: targeting cancer-associated fibroblasts |
Q24620957 | Understanding and treating triple-negative breast cancer |
Q37948053 | Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers |
Q56531587 | Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors |
Q30839232 | h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin. |
Q42443626 | p63: a novel myoepithelial cell marker in canine mammary tissues |
Search more.